Literature DB >> 1168534

Germ-cell malignant tumours in father and son.

M B Musa.   

Abstract

Germ-cell malignant tumours occurred in a man and his son. The father, who had a teratoma of the right testicle removed 24 years ago, is presently alive and well. The son, who had a choriocarcinoma presenting as an abdominal mass, possibly originating in the testicle, died within 7 months of the diagnosis with metastases in the lungs, liver and retroperitoneum. This report documents the third such case of germ-cell neoplasms occurring in father and son.

Entities:  

Mesh:

Year:  1975        PMID: 1168534      PMCID: PMC1959094     

Source DB:  PubMed          Journal:  Can Med Assoc J        ISSN: 0008-4409            Impact factor:   8.262


  5 in total

1.  Familial occurrence of testicular neoplasms: a case report.

Authors:  R M Gulley; R Kowalski; C F Neuhoff
Journal:  J Urol       Date:  1974-11       Impact factor: 7.450

2.  Testicular neoplasms in father and son.

Authors:  J A Arcadi
Journal:  J Urol       Date:  1973-09       Impact factor: 7.450

3.  A new inbred subline of mice (129-terSv) with a high incidence of spontaneous congenital testicular teratomas.

Authors:  L C Stevens
Journal:  J Natl Cancer Inst       Date:  1973-01       Impact factor: 13.506

4.  Testicular neoplasm in father and son.

Authors:  S J Silber; S Cittan; G Friedlander
Journal:  J Urol       Date:  1972-12       Impact factor: 7.450

5.  Lesions of testes observed in certain patients with widespread choriocarcinoma and related tumors. The significance and genesis of hematoxylin-staining bodies in the human testis.

Authors:  J G AZZOPARDI; F K MOSTOFI; E A THEISS
Journal:  Am J Pathol       Date:  1961-02       Impact factor: 4.307

  5 in total
  2 in total

1.  Letter: Testicular tumours in brothers-in-law.

Authors:  R G MacLaren
Journal:  Can Med Assoc J       Date:  1975-09-20       Impact factor: 8.262

2.  Letter: Malignant tumours in father and son.

Authors:  J C Fetterly
Journal:  Can Med Assoc J       Date:  1975-07-26       Impact factor: 8.262

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.